Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,049 | -26,157 | -15,790 | -13,217 | -26,772 |
| Depreciation Amortization | 1,006 | 219 | 157 | 79 | 944 |
| Accounts receivable | -9,078 | -1,628 | -5,734 | 477 | -6,772 |
| Other Working Capital | 5,883 | 8,424 | 667 | 6,997 | -406 |
| Other Operating Activity | 14,703 | 1,765 | 7,951 | 1,619 | 14,289 |
| Operating Cash Flow | $-33,535 | $-17,377 | $-12,749 | $-4,045 | $-18,717 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -2,325 | 16,533 | -17,526 | N/A |
| PPE Investments | -296 | -224 | -52 | -29 | -93 |
| Net Acquisitions | -30,401 | N/A | N/A | N/A | -14,090 |
| Purchase Of Investment | -45,814 | -25,426 | N/A | N/A | -23,861 |
| Sale Of Investment | 59,121 | N/A | N/A | N/A | 1,325 |
| Investing Cash Flow | $-17,390 | $-27,975 | $16,481 | $-17,555 | $-36,719 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 43,687 | 40,057 | 14,056 | 12,914 | 14,073 |
| Debt Repayment | -18,100 | -13,369 | -13,574 | -13,217 | -1,322 |
| Common Stock Issued | 6,324 | 219 | 166 | N/A | 324 |
| Common Stock Repurchased | -3,447 | -3,447 | -3,447 | -3,447 | -4,723 |
| Financing Cash Flow | $28,464 | $23,460 | $-2,799 | $-3,750 | $8,352 |
| Exchange Rate Effect | 44 | -305 | -203 | 65 | 204 |
| Beginning Cash Position | 65,466 | 65,466 | 65,466 | 65,466 | 112,346 |
| End Cash Position | 43,049 | 43,269 | 66,196 | 40,181 | 65,466 |
| Net Cash Flow | $-22,417 | $-22,197 | $730 | $-25,285 | $-46,880 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,535 | -17,377 | -12,749 | -4,045 | -18,717 |
| Capital Expenditure | -296 | -224 | -52 | -29 | -93 |
| Free Cash Flow | -33,831 | -17,601 | -12,801 | -4,074 | -18,810 |